Method for X and Y Spermatozoa Separation by Zavos, Panayiotis M. & Dawson, Karl A.
University of Kentucky
UKnowledge
Animal and Food Sciences Faculty Patents Animal and Food Sciences
3-12-1991





Right click to open a feedback form in a new tab to let us know how this document benefits you.
Follow this and additional works at: https://uknowledge.uky.edu/animalsci_patents
Part of the Animal Sciences Commons
This Patent is brought to you for free and open access by the Animal and Food Sciences at UKnowledge. It has been accepted for inclusion in Animal
and Food Sciences Faculty Patents by an authorized administrator of UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu.
Recommended Citation
Zavos, Panayiotis M. and Dawson, Karl A., "Method for X and Y Spermatozoa Separation" (1991). Animal and Food Sciences Faculty
Patents. 10.
https://uknowledge.uky.edu/animalsci_patents/10
I United ‘States Patent [191 [11] Patent Number: 4,999,283 
Zavos et al. [45] Date of Patent: Mar. 12, 1991 
[54] METHOD FOR X AND Y SPERMATOZOA 4,448,767 5/1984 Bryant ................................... .. 435/2 
SEPARATION 4,511,661 4/1985 Goldberg ........... .. 436/503 
4,680,258 7/1987 Hammerllng et a1. ................ .. 435/7 
[75] Inventors: Panayiotis M. Zavos; Karl A. 
Dawson, both of Lexington, Ky. OTHER PUBLICATIONS 
[73] Assignee: University of Kentucky Research “H'Y Antigen! Genetics and Serology", 1977 Immuno' 
Foundation, Lexington, Ky. $81-$01 RZ’EW, wacshtelk P (M I 
ennett oyse, “ ex atio in rogeny 0 ice nsem 
[21] Appl‘ NO": 396’7‘38 inated with Sperm Treated with H~Y Antiserum". 
[22] Filed: Aug’ 18’ 1989 Primary Examiner—-Robin Teskin 
Attorney, Agent, or Firm—-King & Schickli 
Related US. Application Data 
[63] Continuation of Ser. No. 818,338, Jan. 10, 1986, aban- [57] ABSTRACT 
doned. A method for separating male and female determining 
[51] Int. c1.5 ....................... .. A01N 1/02- c12Q 1/00- spermatozoa includes the initial step “exposing freshly 
’ CIZN 5/06 ejaculated spermatozoa in a substantially protein free 
[52] Us c1. ........ .......................... .. 435/2; 435/721; dm‘em t° an excess concemm‘i‘m of a m°“°°1°“a1 
435/240‘1; 435/2402; 436/501; 436/503; antibody directed against H-Y antigen that binds sub 
436/51O; 436/514; 436/547; 436/548; 436/811; stantially exclusively with male determining spermato 
436/813; 436/824; 436/906; 530/413 20a. The method continues with the suspending of the 
[58] Field of Search ............... .. 435/7, 2, 240.1, 240.2; exposed spermatozoa together with a conjugate of (1) 
436/503, 501, 510, 519, 517, 518, 311, 313, 324, an immunoglobulin G antibody that binds substantially 
906; 530/337, 806, 309, 413 exclusively to the monoclonal antibody and (2) an im 
[56] References Cited munoabsorbant substrate in a substantially protein free 
US. PATENT DOCUMENTS 
3,894,529 7/1975 Shrimpton ............................ .. 435/2 
4,083,957 4/1978 Lang .......... .. 435/2 
4,276,139 7/1981 Lawson ................................. .. 435/2 
diluent. This forms a conjugate/spermatozoa prepara 
tion. The method concludes with the recovering of the 
separated male and female determining spermatozoa. 




METHOD FOR X AND Y SPERMATOZOA 
SEPARATION 
This is a continuation of application Ser. No. 818,338, 
?led Jan. 10, 1986 now abandoned. 
TECHNICAL FIELD 
This invention relates to a method for separating male 
and female determining spermatozoa for the purpose of 
selectively increasing the probability of producing off 
spring of either sex. 
BACKGROUND OF THE INVENTION 
The ability to select the sex of offspring produced in 
fertilization has long been recognized as having tremen 
dous commercial potential and application. An excel 
lent example of this may be found in the ?eld of animal 
husbandry. 
Dairy farm operations require the female of the spe 
cies, cows, for milk production. Males of the species, 
bulls, are only important for breeding purposes. Thus, it 
is clear that any method that safely and effectively in 
creases the production of female offspring versus male 
offspring would greatly bene?t dairy cattle breeders 
and farmers and, therefore, be very valuable. Such a 
method would allow more effective and ef?cient farm 
operation, save money and increase farm milk produc 
tion. 
Of course, it should be recognized that humans may 
also bene?t from such a method of selecting the sex of 
offspring. Parents could very simply satisfy their desires 
to have a son or daughter. This allows improved family 
planning, may reduce family tension and also limit fam 
ily size for the bene?t of all involved. 
Numerous attempts have been made in the past to 
separate x-(male determining) and y-(female determin 
ing) bearing spermatozoa in order to determine the sex 
of the offspring before conception. The methods used 
include centrifugation, ?ltration, electrophoresis, im 
munological techniques and exposure of spermatozoa to 
alkaline or acidic environments. 
Mechanical methods of separating male and female 
determining spermatozoa, based on the difference in 
density between the two types, are disadvantageously 
characterized by reduced spermatozoa survivability 
and by reduced viability of the surviving spermatozoa. 
Immunological methods of spermatozoa separation do 
not suffer as dramatically from these disadvantages. 
U.S. pat. no. 4,448,767 to Bryant discloses two meth 
ods of immunological spermatozoa separation. The ?rst 
method is a single antibody separation system wherein 
male speci?c antibody is bound to sephadex beads 
placed in a column. Native or unseparated spermatozoa 
is then ‘added to the column. The male determining 
spermatozoa become bound to the male specific an 
tibody/Sephadex bead conjugates as the female sperma 
tozoa are eluted from the column. The male determin 
ing spermatozoa are then recovered separately. 
The second method is a dual antibody separation 
system wherein native sperm is treated with male spe 
ci?c antibody. A second antibody, capable of speci? 
cally binding the male speci?c antibody is coupled to 
Sephadex beads placed in a column. The male speci?c 
antibody treated spermatozoa is then added to the col 
umn. The, male determining spermatozoa become 
bound to the second antibody/Sephadex bead conju 







spermatozoa are eluted from the column. The male 
determining spermatozoa are then recovered separately 
as in the ?rst method. 
While the two Bryant methods do serve to increase 
the percentage of mammalian offspring of either sex as 
desired, the methods are not without their disadvan 
tages and, therefore, may be improved. Speci?cally, 
Bryant discloses a complicated technique of animal 
immunization with histocompatability (I-I-Y) antigen 
and multiple repeated absorptions through female 
spleen cells to separate and purify the male speci?c 
antibody used in the Bryant method. Despite this diffi 
cult and tedious technique, it should be appreciated that 
the resulting antibody is still not completely binding 
speci?c to the H-Y antigen found only in male deter 
mining and not female determining spermatozoa. Thus, 
it should be appreciated that a portion of the resulting 
male speci?c antibody used in Bryant could disadvanta 
geously bind through antigens other than the y-antigen 
to some female determining spermatozoa. As a result, 
some female determining spermatozoa are bound to the 
Sephadex beads in the Bryant columns and eluted with 
the male determining spermatozoa fraction. Thus, it is 
clear that the highest levels of effective separation are 
not attainable with the Bryant method. 
Bryant also disadvantageously requires the packing 
of a column with antibody/Sephadex bead conjugate. 
The column must be packed properly so that the rate of 
flow or spermatozoa elution is within a range allowing 
complete immunoreaction between the spermatozoa 
and the antibody of the antibody/bead conjugates. Too 
fast a ?ow rate means incomplete immunoreaction and 
separation and, therefore, the presence of male deter 
mining spermatozoa in the eluted female determining 
spermatozoa fraction. The proper packing of the col 
umn requires a great deal of preparation time and large 
quantities of expensive eluant or ?ltration solution are 
required to complete the separation and recover the 
majority of the spermatozoa from the column. This last 
consideration is particularly important when you con 
sider that different eluants are typically required for 
each species of spermatozoa being separated. Thus, 
large quantities of a number of different and sometimes 
expensive eluants must be stored at the separation lab. 
An additional problem in Bryant relates to the utiliza 
tion of protein containing media for spermatozoa dilu 
tion prior to exposure of the spermatozoa to the anti 
body. Disadvantageously, the protein in the media re 
tards the cross reactivity of the spermatozoa and the 
antibody. It is believed that the existing protein fraction 
in the spermatozoa diluent coats the spermatozoa cov 
ering the histocompatability H-Y antigen sites on the 
male determining spermatozoa and preventing an 
tibody/antigen binding. This causes incomplete separa 
tion as, with either method in Bryant, coated male de 
termining spermatozoa are eluted with the female deter 
mining spermatozoa. 
From the above, it should be appreciated that a need 
exists for an improved method of immunologic sperma 
tozoa separation. 
SUMMARY OF THE INVENTION 
It is, accordingly, one object of the present invention 
to provide a method of spermatozoa separation, based 
on sex determining properties, overcoming the above 
described limitations and disadvantages of the prior art. 
A further object of the present invention is to provide 
an immunological method of spermatozoa separation 
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that is less complicated-and more effective than meth 
ods of the prior art. 
Still another object of the present invention is to 
effectively separate female and male determining sper 
matozoa for subsequent fertilization to produce off 
spring of a selected sex with an increased probability of 
success. 
A still further object of the present invention is to 
provide a method of separating male and female deter 
mining spermatozoa wherein the separated spermatozoa 
have improved ef?cacy and viability. 
Other objects and advantages of the present invention 
will become apparent as the description thereof pro 
ceeds. 
In satisfaction of the foregoing objects and advan 
tages, there is provided by this invention a method for 
separating male and female determining spermatozoa 
for the purpose of selectively increasing the probability 
of producing offspring of either sex during subsequent 
fertilization. 
The method includes the step of exposing unsepa 
rated, native spermatozoa to an excess concentration of 
a ?rst antibody that binds substantially exclusively with 
male determining spermatozoa through the H-Y surface 
antigen. A second antibody covalently bound to an 
immunoabsorbent substrate, such as agarose beads, 
binds substantially exclusively to the ?rst antibody. The 
second antibody/immunoabsorbent conjugates are sus 
pended together with the spermatozoa previously ex 
posed to the ?rst antibody in a protein-free diluent ap 
propriate for the spermatozoa being separated. For 
example, bovine spermatozoa may be suspended in a 
solution of sodium citrate having a pH of approximately 
7.2 and an osmotic pressure of approximately 325 
mOsm. Following immunoreaction in suspension, the 
female determining spermatozoa are recovered while 
the male determining spermatozoa are bound to the 
immunoabsorbent substrate through the first and sec 
ond antibodies. Lastly, if desired, the male determining 
spermatozoa are recovered from the substrate. 
More speci?cally, the native spermatozoa are diluted 
in a protein-free diluent to a concentration of between 
10X 106 to lOOX 106 active spermatozoa per milliliter 
depending on the species being separated. Since the 
diluent is protein free, there is no coating of the surface 
of the spermatozoa and, more particularly, the H-Y 
antigen sites on the male determining spermatozoa. 
Thus, more effective and complete immunoreaction is 
assured between the ?rst antibody and the male deter 
mining spermatozoa. 
Preferably, the ?rst antibody is a male speci?c mono 
clonal antibody directed against H-Y antigen on the 
male determining spermatozoa. These monoclonal anti 
bodies, available from the National Institute of Health, 
are prepared by outgrowth of primary hybridomas and 
recovery of the cultured medium. By using monoclonal 
antibodies of this type, no other antibodies are present in 
the antisera to adversely effect or block the cross reac 
tivity of the antibodies with the I-I-Y antigen on the 
male determining spermatozoa or to bind any other 
antigen such as may be found on the female determining 
spermatozoa. Optimum selective binding is therefore 
assured. 
Following the exposing step, the exposed spermato 
zoa are separated from the excess concentration of the 
?rst antibody. This separation may be performed by 
gentle centrifugation that does not harm the spermato 








acted ?rst antibody and resuspended in fresh protein 
free diluent. 
Preferably, the second antibody coupled to the aga 
rose beads is an anti-immunoglobulin antibody speci?c 
for binding with the male-speci?c, ?rst antibody bound 
to the exposed male spermatozoa. The beads are added 
to the exposed spermatozoa in the protein free diluent 
and the bead/spermatozoa preparation is agitated to 
prevent the beads from settling and thereby assure com 
plete immunoreaction between the two antibodies. 
Again, the protein free diluent prevents antigen “coat 
ing” that can adversely effect the cross reactivity of the 
second antibody with the ?rst antibody and thereby 
reduce separation ef?ciency. 
Following the suspending step, the female determin 
ing spermatozoa may be recovered by draining the 
bead/spermatozoa preparation solution from the aga 
rose beads now bound to the male determining sperma 
tozoa. The drained solution is then gently centrifuged 
and the undamaged female determining spermatozoa 
are recovered in a pellet. The female determining sper 
matozoa may then be resuspended in fresh protein free 
diluent and ?ltered so as to substantially remove all 
dead and weak spermatozoa and increase the ef?cacy of 
the collected fraction. This can done by adding the 
spermatozoa to a column of sephadex beads. The viable 
spermatozoa are then eluted from the column and col 
lected in a protein containing medium for freezing and 
/or subsequent use in arti?cial insemination. 
The male determining spermatozoa are then recov 
ered from the agarose beads. There are many methods 
known in the art for such recovery. The methods in 
clude competitive inhibition using a solution of male 
speci?c antibody, enzymatic digestion of the beads and 
alteration of the pH or salt concentration of the diluent. 
The male determining spermatozoa may then be ?l 
tered and collected as described above so as to substan 
tially remove all dead spermatozoa and increase the 
overall ef?cacy of the fraction. Speci?cally, viable sper 
matozoa pass through the column at a substantially 
faster rate than dead spermatozoa and, therefore, excel 
lent separation results are attainable. 
Still other objects of the present invention will be 
come readily apparent to those skilled in this art from 
the following description wherein there is shown and 
described a preferred embodiment of this invention, 
simply by way of illustration of one of the modes best 
suited to carry out the invention. As it will be realized, 
the invention is capable of other different embodiments 
and, its several details are capable of modi?cations in 
various, obvious aspects all without departing from the 
invention. Accordingly, the drawings and descriptions 
will be regarded as illustrative in nature and not as 
restrictive. 
BRIEF DESCRIPTION OF THE DRAWING 
The accompanying drawing incorporated in and 
forming a part of the specification, illustrates several 
aspects of the present invention, and together with the 
description serves to explain the principles of the inven 
tion. In the drawing: . 
FIG. 1 is a flow sheet illustrating the method of the 
present invention; 
FIG. 2 is a schematical representation showing the 
monoclonal antibody directed against I-I-Y antigen 
binding with the male determining spermatozoa; and 
FIG. 3 is a schematical representation showing the 
binding of the second antibody/bead conjugates to the 
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exposed and monoclonal I-I-Y antibody bound male 
determining spermatozoa. 
DETAILED DESCRIPTION OF THE 
INVENTION 
As shown in FIG. 1, the ?rst step 12 of the method 10 
of the present invention involves exposing live, native 
spermatozoa to an excess concentration of an antibody 
that binds substantially exclusively to male determining 
spermatozoa. Speci?cally, freshly ejaculated spermato 
zoa are diluted to a concentration of between 10X 106 
and lOOX 106 active spermatozoa per milliliter. The 
diluent used varies depending on the species of the 
spermatozoa being separated. Speci?c examples of dilu 
ents include sodium citrate solution for bovine sperma 
tozoa, creme gel buffer for equine spermatozoa and test 
buffer for human spermatozoa. The diluent used, how 
ever, should be free of protein as any protein in the 
diluent tends to coat the spermatozoa and block the 
H-Y antigen binding sites on the surface of the male 
determining spermatozoa. Thus, by substantially elimi 
nating this blocking the method of the present invention 
provides conditions for optimal cross reactivity be 
tween the antibody and antigen for the best possible 
immunoseparation results. 
An excess concentration of the male speci?c antibody 
is contained in or added to the diluent and spermatozoa. 
' The male speci?c antibody is a monoclonal anti-H-Y 
antibody (immunoglobulin G) prepared by outgrowth 
of primary hybridomas and recovered from culture 
medium by stepwise precipitation and dialysis. Such a 
monoclonal antibody is produced by the mouse lym 
phocyte hybrid cell line B6YD1O available from the 
National Institute of Health. 
As shown in FIG. 2, only male determining sperma 
tozoa 14 express the H-Y antigen 16 on their surface. 
The female determining spermatozoa 18 do not express 
the I-I-Y antigen believed associated with the Y or male 
determining chromosome. Since the monoclonal anti 
body 20 is absolutely speci?c for the I-I-Y antigen, it 
binds only to the male determining spermatozoa 14 and 
not any of the female determining spermatozoa 18. 
Following a short incubation period for immunoreac 
tion of, for example, 45 minutes, the spermatozoa/ 
monoclonal H-Y antibody dilution is centrifuged in step 
22 to remove (note FIG. 1)'and collect the exposed 
spermatozoa from the diluent. The exposed spermato 
zoa are then washed (also step 22) using fresh, pure 
protein free diluent in order to‘ remove unbound mono 
clonal antibody. After washing, the exposed spermato 
zoa are resuspended in an equal volume of protein free 
diluent (as used during the exposing step) substantially 
without the presence of unbound H-Y antibody. 
Immediately thereafter, antibody/immunoabsorbent 
conjugates are added to the dilution so as to form a 
conjugate/spermatozoa suspension preparation in step 
24. As shown in FIG. 3, the antibody 26 coupled to the 
immunoabsorbent material or agarose beads 28 binds 
immunoglobulin G and, therefore, binds the mono 
clonal anti-H-Y antibody 20 already bound to the male 
determining spermatozoa 14. Again, just as with the 
first antibody 20, the female determining spermatozoa 
18 do not immunoreact with the immunoglobulin G 
antibody 26 bound to the beads 28. 
In order for the second, immunoglobulin G antibody 
26, to properly react with the monoclonal I-I-Y antibody 
20, the immunoglobulin G antibody must be species 








zoa are exposed to monoclonal H-Y antibody produced 
by mice lymphocyte cells as described above, the sec 
ond antibody bound to the conjugate must be anti 
mouse immunoglobulin G. Such a conjugate of anti 
mouse immunoglobulin G and agarose beads is available 
from Sigma Corporation. ' 
The anti-immunoglobulin G/agarose bead conjugate 
is added to the diluted spermatozoa at an approximate 
concentration of 0.4 milliliters of conjugate beads per 
milliliter of diluted spermatozoa (assuming a minimum 
of 0.4 milligrams of mouse immunoglobulin G may be 
bound and eluted from each milliliter of antibody 
bound beads). The conjugate/spermatozoa preparation 
is incubated at approximately 37° C. and agitated to 
prevent the beads from settling and thereby maintain 
the beads and spermatozoa in physical contact for com— 
plete immunoreaction. During this time, the anti 
immunoglobulin G antibody of the conjugate binds the 
monoclonal H-Y antibody bound to the male determin‘ 
ing spermatozoa as shown in FIG. 3. Thus, the an“ 
tibody/bead conjugate agglutinates the monoclonal 
antibody/male determining spermatozoa complexes. 
Following immunoreaction and agglutination, the ‘ 
female determining spermatozoa are recovered at step 
30. This step may be completed by draining the con 
jugate/spermatozoa preparation solution from the an 
tibody/agarose bead conjugates now bound to the male 
determining spermatozoa. Since the female determining 
spermatozoa do not bind to the beads (note FIG. 3), the 
female determining spermatozoa are contained in this 
drained solution. The solution is then gently centrifuged 
to collect the female determining spermatozoa in a pel 
let at the bottom of the centrifuge tube without signi? 
cantly adversely affecting spermatozoa viability. 
A Sephadex ?ltering column is then prepared as is 
known in the art. The pelleted female determining sper 
matozoa are then resuspended in a diluent and added in 
step 32 to the ?ltering column. Viable spermatozoa pass 
through or are eluted from the column at a substantially 
faster rate than dead or weak spermatozoa and, there 
fore, excellent ?ltering results are obtainable. The sper 
matozoa eluted from the column may be collected in a 
protein containing medium for maintaining the sperma 
tozoa for freezing and/or subsequent use in arti?cial 
insemination. An example of such a protein containing 
medium is the protein free diluent used above during 
the exposing and suspending steps mixed with egg yolk, 
20% by volume. 
The male determining spermatozoa are also recov 
ered at step 34 from the agarose beads. There are many 
methods known in the art for such recovery. The meth 
ods include competitive inhibition using a solution of 
male speci?c antibody, enzymatic digestion of the 
beads, and alteration of the pH or salt concentration of 
the diluent. Following recovery, the male determining 
spermatozoa are ?ltered in step 36 through a Sephadex 
column in the same manner as the female determining 
spermatozoa so as to increase the efficacy of the male 
determining spermatozoa fraction or sample. 
The following examples are presented to further illus 
trate the invention, but it is not to be considered as 
limited thereto. 
EXAMPLE 1 
HY antibody is obtained by outgrowth of a mono 
clonal hybridoma cell culture (American Type Culture 
Collection, Number, B6YD10). The cell culture is 
grown in RPMI 1640 medium with L-Glutamine (M.A. 
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Bioproducts) containing 200 Units of Gentomycin per 
ml and supplemented with 20% fetal bovine serum. The 
growth environment is an incubator gassed via 5% CO2 
in air and maintained at 37“ C. Supernatant is harvested 
at 48-hour intervals and frozen at —-20° C. environment 
until processing. The antibody (globulin fraction) is 
collected from the supernatant by precipitation with 
50% saturated ammonium sulfate (3 X). The ammonium 
sulfate is then removed via dialysis against sodium ci 
trate diluent (SCD). During this process, globulin frac 
tions are concentrated into a volume which is one tenth 
of the original culture fluid collected. The recovered 
globulin fractions are aliquoted into 1 ml fractions, fro 
zen, and maintained at —-70° C. environment until use. 
EXAMPLE 2 
Bovine spermatozoa are collected by any appropriate 
method known in the art. The semen is collected di 
rectly into a prewarmed vessel at 37° C. and maintained 
at this temperature until dilution 10 to 15 minutes later. 
The freshly ejaculated bovine spermatozoa are diluted 
to 40><106 active spermatozoa per ml by adding an 
appropriate quantity of physiologically balanced so 
dium citrate solution at 325 m Osm/liter, pH 7.2, and 
free of protein. An excess concentration of 1:200 mono 
clonal antibody directed against HY antigen as pre 
pared in Example 1 is then added to the diluted sperma 
tozoa. The spermatozoa preparation is then incubated 
for a period of 45 minutes at 37° C. The preparation is 
then centrifuged for 10 minutes at 1,000 g and the sper 
matozoa collected in a pellet. The spermatozoa pellet is 
then resuspended in an equal volume of sodium citrate 
solution without the HY antibody. Immediately thereaf 
ter, 0.4 ml of agarose beads covalently bound with anti 
mouse IgG (available from Sigma Chemical Company, 
St. Louis, Mo.) are added per ml of diluted spermato 
zoa. This spermatozoa-agarose bead suspension is then 
incubated for 30 minutes at 37“ C. Since the beads settle 
to the bottom of the suspension if allowed to set for ?ve 
minutes or longer, the suspension is agitated or mixed 
every 10 minutes to keep the sperm and beads in physi 
cal contact. At the end of the 30 minute incubation 
period, the sperm fraction is collected by decanting or 
draining the supernatant. Following collection, the 
sperm fraction is transferred and layered on top of a 
Sephadex sperm'?ltration column and ?ltered. 
Actually, the column consists of three disposable 
plastic syringes each 1 cm in diameter and 6.5 cm high. 
A pad of Johns-Manville Micro-Fiber, code 112, No. 
475 glass, is prepared by taking thin sheets of 3 to 4 mg 
?ber and folding the long ?bers under to make a circle 
of approximately 1 cm in diameter. A pad is then gently 
pushed to the bottom of each syringe using a Pasteur 
pipet until l to 2 mm protrudes through the hole in the 
syringe. The ?bers are inspected so that no holes should 
be evident in the syringe. Twenty g of Sephadex G 15 
(40-120 particle size) are added to 100 ml of diluent, 34 
g/liter, 320 mOsm osmotic pressure. The sephadex is 
then allowed to swell at 5° C. for 4 hours. Each syringe 
is ?lled with sodium citrate solution to the 2.5 ml level. 
A volume of 0.8 ml of rapidly mixing Sephadex slurry is 
then added to the diluent in each syringe. The Sephadex 
is allowed to settle for 10 minutes and then the ?lter is 
ready for use. The Sephadex column should be set at 8 
mm height. More Sephadex may be added, if necessary, 
until the level reaches the 8 mm mark. The ?lters are 
?rmly held in a vertical position and a beaker is used to 










Flow rates are adjusted to approximately 0.5-0.7 ml 
per minute measured by the 2.5-1.5 ml markings on the 
syringe-?lters. Fast flow rates indicate insuf?cient ?ber 
glass or holes in the ?berglass pads which would allow 
Sephadex to pass into the collection vials. Slow flow 
rates, however, are caused by too much ?berglass in the 
pad and may result in insuf?cient ?ltering. The ?lters 
are allowed to drain to the 1 ml mark and then the ?lter 
is re?lled with the diluent from a wash bottle, taking 
care not to disturb the Sephadex surface. The ?lters are 
allowed to drain to the 2.5 ml level and the beaker is 
replaced with a 20 ml volumetric ?ask and a 1 ml semen 
sample containing 40X 106 active spermatozoa is added 
or layered to the top of the column. All samples are 
mixed immediately before sampling to assure accuracy. 
Adequate time is allowed for the ?lter to drain to 1.2 ml 
mark and then to be re?lled to the top with additional 
sodium citrate solution. 
Male determining spermatozoa are recovered as fol 
lows. Agarose beads recovered following draining of 
the female determining spermatozoa are mixed with 
monoclonal H-Y antibody twice the original concentra 
tion used during the female determining spermatozoa 
separation procedure. As it may be noted, the agarose 
heads at the end of the separation procedure formed 
complexes made out of the antibody/bead conjugate 
which agglutinated the monoclonal antibody/ male de 
termining spermatozoa. The added H-Y antibody in 
excess (2X the original concentration) is mixed gently 
via agitation to break the bondage of the male spermato 
zoa and the agarose bead. As the bondage is broken, the 
H-Y antibody then cross reacts with the anti-immuno 
globulin G site on the agarose bead rendering it inactive 
(inhibited). The method via which the process of sepa 
ration of the male determining spermatozoa form the 
bead conjugates is otherwise known as competitive 
inhibition. The agitation for purposes of separation of 
the male spermatozoa may continue for 30 minutes (at 
37° C.) or until no visible physical bondage between the 
beads and the spermatozoa is evident. Following this. 
the agitated solution is allowed to sit for an additional 
30 minutes to allow the beads to settle to the bottom of 
the container and then the supernatant is removed 
which would contain the freed male spermatozoa (37° 
C.). Following recovery the male determining sperma 
tozoa are ?ltered in step 36 through a Sephadex column 
in the same manner as the female determining spermato 
zoa and processed either for arti?cial insemination or 
for cryopreservation purposes. 
We claim: 
1. The method for separating male and female deter 
mining spermatozoa for the purpose of controlling the 
sex of offspring prior to conception, comprising the 
steps of: 
exposing the spermatozoa in a protein free diluent to 
an excess concentration of a ?rst antibody that 
binds male determining spermatozoa; 
, suspending said exposed spermatozoa together with a 
conjugate of a second antibody that binds exclu 
sively to said ?rst antibody and an immunoabsorb 
ent substrate in a protein free diluent to form a 
conjugate/spermatozoa preparation; and 
recovering the female determining spermatozoa from 
the conjugate/spermatozoa preparation while said 
male determining spermatozoa are bound to said 
immunoabsorbent substrate. 
2. The method for separating male and female deter 
mining spermatozoa recited in claim 1, including the 
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additional step of recovering said male determining 
spermatozoa from said immunoabsorbent substrate. 
3. The method for separating male and female deter 
mining spermatozoa recited in claim 1, wherein said 
exposing step includes the additional step of diluting 
said spermatozoa to a concentration of between 
10X 106 and lOOX 106 active spermatozoa per milliliter 
of protein free diluent. 
4. The method for separating male and female deter 
mining spermatozoa recited in claim 1, wherein said 
?rst antibody is monoclonal antibody directed against 
H-Y antigen of said male determining spermatozoa. 
5. The method for separating male and female deter 
mining spermatozoa recited in claim 1, including the 
steps of recovering said exposed spermatozoa from said 
excess concentration of said ?rst antibody and washing 
said exposed spermatozoa to remove unbound ?rst anti 
body. 
6. The method for separating male and female deter 
mining spermatozoa recited in claim 5, wherein said 
recovering is by centrifugation. 
7. The method for separating male and female deter 
mining spermatozoa recited in claim 5, including the 
step of resuspending said washed, exposed spermatozoa 
in a protein free diluent. 
8. The method for separating male and female deter 
mining spermatozoa recited in claim 1, including the 
additional step of incubating said spermatozoa at ap 
proximately 37“ C. during said exposing and suspending 
steps. 
9. The method for separating male and female deter 
mining spermatozoa recited in claim 1, wherein said 
immunoabsorbent substrate is agarose beads. 
10. The method for separating male and female deter 
mining spermatozoa recited in claim 1, wherein said 
second antibody is anti‘immunoglobulin antibody capa 
ble of binding said ?rst antibody. 
11. The method for separating male and female deter 
mining spermatozoa recited in claim 1, wherein said 








said conjugate/spermatozoa preparation to prevent the 
immunoabsorbent substrate from settling. 
12. The method for separating male and female deter 
mining spermatozoa recited in claim 1, wherein said 
female determining spermatozoa recovering step in 
cludes the steps of draining said protein free diluent and 
female determining spermatozoa from said immunoab 
sorbent substrate and then centrifuging said protein free 
diluent and female determining spermatozoa to separate 
said female determining spermatozoa from said diluent. 
13. The method for separating male and female deter 
mining spermatozoa recited in claim 1, including the 
additional step of ?ltering the separated female deter 
mining spermatozoa so as to substantially remove dead 
spermatozoa and increase overall ef?cacy. 
14. The method for separating male and female deter 
mining spermatozoa recited in claim 13, wherein said 
?ltering step includes the step of passing the separated 
female determining spermatozoa through an unbound 
sephadex bead column. 
15. The method for separating male and female deter 
mining spermatozoa recited in claim 2, including the 
additional step of ?ltering the separated male determin 
ing spermatozoa so as to substantially remove dead 
spermatozoa and increase overall ef?cacy. 
16. The method for separating male and female sper~ 
matozoa recited in claim 2, including the additional 
steps of separately ?ltering the separated male and fe 
male determining spermatozoa so as to remove dead 
spermatozoa and increase overall ef?cacy and sepa 
rately collecting said separated male and female deter 
mining spermatozoa in a protein containing media fol 
lowing ?ltering, said protein containing media serving 
to support the separated spermatozoa until subsequent 
use in arti?cial insemination. 
17. The method for separating male and female deter 
mining spermatozoa recited in claim 1, wherein said 
protein free diluent is a sodium citrate buffer. 
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